These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7144066)

  • 21. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension.
    Mills PR; Rae AP; Farah DA; Russell RI; Lorimer AR; Carter DC
    Gut; 1984 Jan; 25(1):73-8. PubMed ID: 6360815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of molsidomine on portal and cardiac hemodynamics in liver cirrhosis].
    Hüppe D; Jäger D; Tromm A; Tunn S; Barmeyer J; May B
    Dtsch Med Wochenschr; 1991 May; 116(22):841-5. PubMed ID: 2036943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained release metoprolol: a comparison with conventional formulation in the treatment of hypertension.
    Logan RL; Goldstraw PW; Kiddle GB; Flacks LM; Watt M
    N Z Med J; 1981 Jul; 93(687):1-2. PubMed ID: 7022275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carvedilol for portal hypertension in patients with cirrhosis.
    Bosch J
    Hepatology; 2010 Jun; 51(6):2214-8. PubMed ID: 20513005
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies with a new cardioselective beta-blocker, metoprolol.
    Werkö L; Aurell M; Johnsson G; Sannerstedt R; Svedmyr N
    Adv Clin Pharmacol; 1976; 11():19-25. PubMed ID: 1032569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of portal hypertension with nadolol in patients with liver cirrhosis.
    Cervera J; Torres-Zamora M; Gutiérrez-Carreño R; Fierro M; Schaeffer L; Landa L
    Arch Invest Med (Mex); 1983; 14(4):331-41. PubMed ID: 6678555
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.
    Lin HC; Yang YY; Hou MC; Huang YT; Lee FY; Lee SD
    Am J Gastroenterol; 2004 Oct; 99(10):1953-8. PubMed ID: 15447755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of carvedilol a nonselective beta-blocker on portal hemodynamics in cirrhosis.
    Fierbinteanu-Braticevici C; Udeanu M; Dragomir P; Andronescu D
    Rom J Intern Med; 2003; 41(3):247-54. PubMed ID: 15526508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of selective blockade of beta 2-adrenergic receptors on portal and systemic hemodynamics in a portal hypertensive rat model.
    Kroeger RJ; Groszmann RJ
    Gastroenterology; 1985 Apr; 88(4):896-900. PubMed ID: 2857673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antihypertensive effects of metoprolol and reserpine-hydrochlorothiazide.
    Lochaya S; Jansiriskul V; Srivorpongpan R; Jiamsucson K; Suvachittanont O
    J Med Assoc Thai; 1982 Apr; 65(4):203-12. PubMed ID: 7050277
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of portal hypertension with isosorbide dinitrate alone and in combination with vasopressin.
    Hallemans R; Naeije R; Mols P; Mélot C; Reding P
    Crit Care Med; 1983 Jul; 11(7):536-40. PubMed ID: 6861502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relation of cardiovascular response to the hypotensive effect of metoprolol.
    Fouad FM; Tarazi RC; Bravo EL
    Am Heart J; 1982 Oct; 104(4 Pt 1):803-11. PubMed ID: 7124594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension.
    Merkel C; Gatta A; Zuin R; Finucci GF; Nosadini R; Ruol A
    Digestion; 1985; 32(2):92-8. PubMed ID: 2864299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Once-daily metoprolol in primary hypertension.
    Karlberg BE; Nilsson O; Tolagen K; Nitelius E; Waern U
    Clin Pharmacol Ther; 1979 Apr; 25(4):399-407. PubMed ID: 371902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Medical therapy of portal hypertension].
    Baldassarre G; Ventrella F; Gadaleta CD
    Clin Ter; 1986 May; 117(4):355-60. PubMed ID: 3731740
    [No Abstract]   [Full Text] [Related]  

  • 37. Portal and systemic effects of selective infusion of vasopressin into the superior mesenteric artery in cirrhotic patients.
    Millette B; Huet PM; Lavoie P; Viallet A
    Gastroenterology; 1975 Jul; 69(1):6-12. PubMed ID: 1150036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding.
    Laleman W; Nevens F
    Minerva Med; 2006 Aug; 97(4):325-45. PubMed ID: 17008837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of acute myocardial infarction with metoprolol (author's transl)].
    Wirtzfeld A; Klein G; Delius W; Sack D
    Dtsch Med Wochenschr; 1978 Mar; 103(13):566-74. PubMed ID: 639687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. β-Blocker therapy for cirrhotic cardiomyopathy: a randomized-controlled trial.
    Silvestre OM; Farias AQ; Ramos DS; Furtado MS; Rodrigues AC; Ximenes RO; de Campos Mazo DF; Yoshimura Zitelli PM; Diniz MA; Andrade JL; Strunz C; Friedmann AA; Lee SS; Carrilho FJ; D'Albuquerque LAC; Bacal F
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):930-937. PubMed ID: 29979644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.